RecruitingACTRN12623000473662

Assessing parkrun for walking rehabilitation for people living with, and beyond, cancer: acceptability, physical function, wellness and group support

Feasibility study - assessing parkrun for walking rehabilitation for people living with, and beyond, cancer: acceptability, physical function, wellness and group support


Sponsor

University of the Sunshine Coast

Enrollment

100 participants

Start Date

Mar 4, 2024

Study Type

Interventional

Conditions

Summary

The purpose of this study is to determine if parkrun is an acceptable and enjoyable type of physical activity for cancer survivors or those currently with cancer. Who is it for? You may be eligible for this study if you are an adult who has survived any type of cancer, or if you are currently undergoing treatment for any type of cancer. Study Details All participants in this study will complete a 4 week review period to monitor activity levels, before registering with parkrun and being encouraged to join in their local parkrun walk event each Saturday morning, or at their own discretion depending upon their health status, for 6 months. Physical function will be measured before and after the intervention. Participants will then be asked to complete questionnaires to determine whether parkrun is an acceptable and enjoyable physical activity, and to assess impact on physical and mental health. It is hoped that the study may provide much-needed evidence that parkrun is accessible, inclusive, supportive, safe and effective, and that it can provide real benefits for patients that can be translated into clinical practice.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 90 Yearss

Inclusion Criteria1

  • Cancer survivors, aged 18 years or over, diagnosed with any type of cancer (e.g. breast, prostate, colorectal, blood, bone), who have medical clearance to walk and exercise, are eligible for the study. “Cancer survivor” is described as undergoing medical treatment or in remission. Participants would be classified according to the Palliative Care Outcomes Classification (PCOC); either Stage 1 (stable) or Stage 2 (unstable but not deteriorating) Participants must have given informed consent and must be registered with parkrun before start of the first walk/run event. Participants must be able to understand and communicate in English or participate with a carer/support person who can communicate in English. Finally, participants must be able to commit to the 9-month period of the study.

Exclusion Criteria1

  • Cancer survivors are ineligible for this study if they are unable to walk, are classified by the PCOC as Stage 3 (deteriorating) or 4 (terminal) or are undergoing end-of-life care, and if they do not have medical clearance to at least walk or do other light exercise. Potential participants will also be excluded if they have a serious medical condition such as uncontrolled cardiac disease (e.g. angina, arrythmias, heart failure) and/or hypertension; serious pulmonary disease where forced vital capacity (FVC1) is less than 1 litre; uncontrolled metabolic or renal disease; a current musculoskeletal injury that might cause pain during walking or jogging; a neurological condition that is a falls or exercise risk for participants; severe visual, and/or auditory impairment, or behavioural, cognitive or psychological disorder, that would affect understanding and complying with clear instructions or communicating with others. Patients are ineligible for the study if they cannot communicate in, or understand, English or follow verbal instructions from parkrun volunteers and/or a carer/support person who can speak English.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Regular exercise for cancer survivors is strongly recommended yet the majority of individuals do not meet the recommended levels of physical activity. Common reasons for low participation rates includ

Regular exercise for cancer survivors is strongly recommended yet the majority of individuals do not meet the recommended levels of physical activity. Common reasons for low participation rates include access issues, poor levels of baseline fitness, fitting exercise around medical appointments and treatments, disease symptoms and treatment side effects. This study will investigate the feasibility and efficacy of the weekly walk/run community event parkrun as a means of providing exercise, social connections and mental health management for people surviving cancers. The study has 4 data collection timepoints: T1 Baseline assessments; T2 Data collection after a 4-week control period (no intervention, normal daily activities); T3 completion of 6-month parkrun intervention; T4 2-month follow up. Parkrun can be a walk or run event, and is self-paced and well-monitored by volunteers, therefore has the potential to be a manageable, safe mode of exercise for individuals with low functional capacity. This project will investigate the feasibility of parkrun as a mode of physical activity for cancer survivors, with regard to acceptability, enjoyment and social identification for participants, and efficacy in maintaining or improving physical and functional status, and quality of life. This study is a 9-month prospective, cohort study, classified as a cross-over design where all participants act as their own controls and can engage in the same intervention. The study uses mixed methods. After recruitment, finalisation of informed consent procedures and screening, there will be a baseline data collection at the University of the Sunshine Coast (USC) exercise science laboratory (T1; medical history, physical assessments, surveys [including quality of life, physical activity levels, anxiety and depression, diet]) followed by 4 weeks of normal daily activities for participants (control period, no parkrun intervention). After 4 weeks (T2) all outcome measures will be assessed again at the USC laboratory prior to starting the parkrun intervention; participants will register with parkrun and then be encouraged to participate in their local parkrun walk event each Saturday morning or at their own discretion depending upon their health status. We understand that participants will have a variety of cancer types, and at different stages with varying types of treatments, and so may not be able to commit to doing weekly parkruns. After 6 months (T3), all outcome measures will be assessed again at the University laboratory and an additional paper survey of participant feedback and comments will be administered. There will be a 2-month follow-up (T4) of an additional survey (posted hard copy) seeking information on continuity of parkrun involvement, diet and exercise. The physical assessments and surveys will be administered by members of the research team who are academics and trained exercise physiologists with between 10 to 20 years experience; the dietary assessment questionnaire will be administered by a researcher who is a trained dietician of more than 10 years experience. Project participants will be community-dwelling out-patients. They may be undergoing treatments or in remission. They will have the choice of joining in a weekly parkrun for the 6 month intervention. Parkrun events are held at Sunshine Coast parks - Mujimba, Brightwater, Baringa, Kawana, Golden Beach, Nambour, Maleny and Noosa. Parkrun attendance is automatically monitored by the parkrun organisation itself as participants scan a personal barcode prior to beginning each event; the deidentified information is registered at parkrun thus adherence can be monitored through the study. Participants do not have to complete the full 5km walk or jog and can participate in the event at their own pace, and with social or carer support if needed. Research team members will be able to attend some of the parkrun events to meet with participants although we cannot attend every event at each location. Research team connection will help with participant adherence.


Locations(6)

The Sunshine Coast Private Hospital - Buderim

QLD, Australia

Sunshine Coast University Private Hospital - Birtinya

QLD, Australia

Sunshine Coast University Hospital - Birtinya

QLD, Australia

Sunshine Coast Haematology and Oncology Clinic - Maroochydore

QLD, Australia

University of Sunshine Coast Health Clinics - Sippy Downs

QLD, Australia

Noosa Hospital - Noosaville

QLD, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12623000473662


Related Trials